Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Neutral Schroders (SDR) by JP Morgan
- Sell Jaywing (JWNG) by Steve Moore in ShareProphets
- Sell Jubilee Metals Group (JLP) by Tom Winnifrith in ShareProphets
- Sell Jubilee Metals Group (JLP) by Steve Moore in ShareProphets
- Sell Tribe Technology (TRYB) by Steve Moore in ShareProphets
- Outperform Hollywood Bowl Group (BOWL) by RBC Capital
- Buy JD Sports Fashion (JD.) by Harvey Jones in The Motley Fool
- Hold Legal & General Group (LGEN) by Harvey Jones in The Motley Fool
- Sell Gelion (GELN) by Steve Moore in ShareProphets
- Buy GSK (GSK) by Harvey Jones in The Motley Fool
- Neutral Synthomer (SYNT) by UBS
- Neutral Carvana Co Class A (0A79) by UBS
- Equal Weight United Utilities Group (UU.) by Barclays
- Overweight Workspace Group (WKP) by Barclays
- Equal Weight Safestore Holdings (SAFE) by Barclays
- Equal Weight Severn Trent (SVT) by Barclays
- Overweight Pennon Group (PNN) by Barclays
- Overweight Land Securities Group (LAND) by Barclays
- Overweight LondonMetric Property (LMP) by Barclays
- Overweight Convatec Group (CTEC) by Barclays
PureTech Health (PRTC) Share Price
Health Care Sector
NOTE: This is based on 145 open tips for PureTech Health (PRTC)
| Latest Bid : 156.40p | Latest Ask : 156.80p |
| High Today : 159.60p | Low Today : 154.60p |
| This Years High : 237.50p | This Years Low : 141.40p |
| Volume : 691,749 | MKT Cap : £374.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
PureTech Health (PRTC) Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
PureTech Health (PRTC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2024-12-16 15:01:00 16/12/2024 | -10.83% |
| Watch | Harvey Jones | Premium Only | 2024-08-21 13:55:00 21/08/2024 | – |
| Buy | Alan Oscroft | Premium Only | 2024-06-26 18:30:00 26/06/2024 | -19.46% |
| Avoid | Mark Tovey | Premium Only | 2024-01-08 12:10:00 08/01/2024 | 24.43% |
| Hold | Alan Oscroft | Premium Only | 2023-08-29 14:25:00 29/08/2023 | -18.37% |
PureTech Health (PRTC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 156.40p | Latest Ask : 156.80p |
| High Today : 159.60p | Low Today : 154.60p |
| This Years High : 237.50p | This Years Low : 141.40p |
| Volume : 691,749 | MKT Cap : £374.75M |
PureTech Health Overview
PureTech Health plc ("PureTech Health", "PureTech" or "the Company") is a clinical-stage biotherapeuticscompany dedicated to discovering, developing and commercializing highly differentiated medicines for
devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers,
lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.
NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest PureTech Health Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Jefferies | Premium Only | 2024-12-16 15:01:00 16/12/2024 | -10.83% |
| Watch | Harvey Jones | Premium Only | 2024-08-21 13:55:00 21/08/2024 | – |
| Buy | Alan Oscroft | Premium Only | 2024-06-26 18:30:00 26/06/2024 | -19.46% |
| Avoid | Mark Tovey | Premium Only | 2024-01-08 12:10:00 08/01/2024 | 24.43% |
| Hold | Alan Oscroft | Premium Only | 2023-08-29 14:25:00 29/08/2023 | -18.37% |